Abstract
Treatment of cancer patients with lipid A analogs is now feasible. This is the culmination of a long story, beginning hundreds of years ago, of progress in different scientific fields bacteriology, chemistry, immunology, genetics, cell biology and experimental medicine. Knowing the history of this domain of research is important in understanding why there is increasing acceptance among the scientific community of attempts to treat cancer with lipid A analogs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Galanos C, Lehmann V, Luderitz O et al. Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur J Biochem 1984; 140:221–227.
Takayama K, Qureshi N, and Mascagni P et al. Complete structure of lipid A obtained from the lipopolysaccharides of the heptoseless mutant of Salmonella typhimurium. J Biol Chem 1983; 258:12801–12803.
Sultzer B M. Genetic control of leucocyte responses to endotoxin. Nature 1968; 219:1253–1254.
Rosenstreich DL, Vogel SN, Jacques AR., Wahl LM et al. Macrophage sensitivity to endotoxin: genetic control by a single codominant gene. J Immunol 1978; 121:1664–1670.
Wright SD, Tobias PS, Ulevitch RJ et al. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 1989; 170:1231–1241.
Wright SD, Ramos RA, Tobias PS et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431–1433.
Medzhitov R, Preston-Hurlburt P and Janeway CA, Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394–397.
Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/I0ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085–2088.
Bretscher P, and Cohn M. A theory of self-nonself discrimination. Science 1970; 169:1042–1049.
Medzhitov R, and Janeway CA, Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9:4–9.
Medzhitov R, and Janeway, CA, Jr. Innate immune recognition and control of adaptive immune responses. Semin Immunol 1998; 10:351–353.
Matzinger P. The danger model: a renewed sense of self. Science 2002; 296:301–305.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Jeannin, JF. (2009). Introduction: Historical Background. In: Jeannin, JF. (eds) Lipid A in Cancer Therapy. Advances in Experimental Medicine and Biology, vol 667. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1603-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1603-7_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1602-0
Online ISBN: 978-1-4419-1603-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)